A 55-Year-Old Man with Muscle-Invasive Bladder Cancer - Episode 4

Adjuvant Therapy Regimen Considerations for Patients with MIBC

January 23, 2023

Dr Matthew Galsky explains the adjuvant therapy regimen he would have recommended for the patient with MIBC from the presented case, and whether patient preference factors into his decisions in clinical practice.

EP. 1: Case Presentation: A 55-Year-Old Man with Muscle-Invasive Bladder Cancer (MIBC)

EP. 2: Available Adjuvant Therapy Options After Cystectomy for Patients with Stage II or III MIBC

EP. 3: Safety and Efficacy Data from CheckMate 274 on Adjuvant Nivolumab Therapy for Patients with MIBC

Now Viewing

EP. 4: Adjuvant Therapy Regimen Considerations for Patients with MIBC

EP. 5: Critical Unmet Needs for Patients with MIBC and Ongoing Clinical Trials in the Neoadjuvant Setting

EP. 6: Approaches to Neoadjuvant and Adjuvant Immunotherapy for Patients with MIBC